Lamotrigine 25

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

EpilepsySuicide

221 competitors in Epilepsy

#DrugCompanyPhaseTrials

1

Briviact

UCB

Phase 3

142

Epidiolex

Jazz Pharmaceuticals

Phase 3

93

Depacon

AbbVie

Phase 3

14

Dayvigo

Eisai

Phase 3

15

Zonegran

AAzurity Pharmaceuticals

Phase 3

56

Fintepla

IImmedica Pharma AB

Phase 3

47

Actemra

Roche

Phase 3

—8

Deltavit

HHyundai Pharmaceutical Co., LTD.

Phase 3

39

Narcan

SScienture

Phase 3

110

GWP42003-P

Jazz Pharmaceuticals

Phase 3

1Show 31 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Pregnancy2 trials

Lamotrigine Pregnancy Registry (LAM05)

Completed·GSK··NCT01064297·3,416 enrolled

Birth Defects Associated With Exposure to Lamotrigine in Pregnancy (EUROCAT)

Completed·GSK··NCT01055327·1 enrolled

MPR2 trials

The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 100mg Compared With Compressed Tablet 100 mg

Completed·GSK·Phase 1·NCT02064465·138 enrolled

The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 5mg×5 Compared With Lamotrigine Compressed Tablet 25mg in Chinese Healthy Male Subjects

Completed·GSK·Phase 1·NCT01879423·24 enrolled

LAM2 trials

Bioequivalence And Effect Of Food And Water On Lamotrigine in Healthy Volunteers

Completed·GSK·Phase 1·NCT00449774·220 enrolled

Bioequivalence and Food Effect of 250mg of Lamotrigine XR

Completed·GSK·Phase 1·NCT00605371·209 enrolled

Suicide1 trial

WEUKBRE5557: IMI PROTECT(Work Package 2): Antiepileptics & Suicide

Completed·GSK··NCT01607333·1 enrolled

Epilepsy1 trial

Valproate Dose Reduction and Its Clinical Evaluation by Introducing Lamotrigine in Japanese Women With Epilepsy - Single Arm, Multicenter, and Open-label Study

Completed·GSK·Phase 4·NCT02100644·33 enrolled

Details

Drug Info

Related News